Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ROIV
Stock Latest News
The Fly
Roivant Sciences files automatic mixed securities shelf
8d ago
ROIV
Premium
Ratings
Hold Rating for Roivant Sciences Amid Promising Developments and Competitive Challenges
16d ago
ROIV
Premium
Market News
3 Best Stocks to Buy Now, 9/19/2025, According to Top Analysts
22d ago
IVA
NVDA
Premium
The Fly
Roivant Sciences price target raised to $16.50 from $12 at BofA
23d ago
ROIV
Premium
The Fly
TD Cowen initiates $23 price target for Roivant Sciences
23d ago
ROIV
Premium
The Fly
Roivant Sciences price target raised to $20 from $18 at Jefferies
23d ago
MRNA
ROIV
Premium
The Fly
Roivant Sciences price target raised to $21 from $15 at Guggenheim
23d ago
ROIV
Premium
The Fly
Roivant Sciences price target raised to $20 from $16 at JPMorgan
23d ago
ROIV
Premium
The Fly
Roivant Sciences price target raised to $20 from $18 at H.C. Wainwright
23d ago
ROIV
Premium
Ratings
Yaron Werber’s Buy Rating Highlights Brepocitinib’s Potential as a Leading Treatment for Dermatomyositis
24d ago
ROIV
Premium
The Fly
Roivant Sciences rises 11.2%
24d ago
ROIV
Premium
The Fly
General Mills reports Q1 beat, Rithm to acquire Paramount Group: Morning Buzz
24d ago
CG
TS
Premium
The Fly
Roivant Sciences rises 12.0%
24d ago
ROIV
Premium
Company Announcements
Roivant Sciences Announces Positive Phase 3 Study Results
24d ago
8K
ROIV
Premium
The Fly
Roivant, Priovant reports Phase 3 VALOR study results for brepocitinib
24d ago
ROIV
Premium
Company Announcements
Roivant Sciences Approves Proposals at Annual Meeting
30d ago
8K
ROIV
Premium
Ratings
Promising Pipeline and Strategic Positioning of Roivant Sciences: A Buy Recommendation with a $16 Price Target by 2025
1M ago
ROIV
Premium
The Fly
Pulmovant receives orphan drug designation from Japan MHLW for mosliciguat
1M ago
ROIV
Premium
Company Announcements
Roivant Sciences Announces Promising Study Results
1M ago
8K
ROIV
Premium
The Fly
Roivant Sciences shares six-month off-treatment data in GD patients
1M ago
ROIV
Premium
The Fly
Roivant Sciences initiated with a Buy at Citi
1M ago
ROIV
Premium
Ratings
Positive Outlook for Roivant Sciences Driven by Brepocitinib’s Phase 3 Potential and Undervalued Stock
1M ago
ROIV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
